Gig Harbor,
Washington state

mobile logo

Press & Awards

Northstar announces manufacturing and distribution deals signed for first Medical Marijuana product

Holbrook, New York, June 4, 2014 – Northstar Global Business Services, Inc., Symbol (OTCPink:MDIN) today announced that it has executed an agreement with Kush Creams™, one of the leading Medical marijuana growers and distributors based out of Washington state, to not only manufacture Northstar’s first medical marijuana product, Snorenz Medicated©, but also to distribute the product to a long list of marijuana dispensaries throughout the State.


The deal has Kush Creams™ starting a significant manufacturing run immediately, in order to have enough inventory for the initial orders. It is expected that approximately a hundred dispensaries will start out carrying Snorenz Medicated, and that number is expected to grow significantly as the product begins to capitalize on Snorenz’s existing brand awareness. Once dispensaries that already carry various Kush Creams™ products see that Snorenz Medicated is available, it is fully expected that the penetration of the market will increase very quickly.


Northstar maintains that its research has shown that many legal marijuana users are already taking some form of Marijuana at night in order to relax and sleep better. Adding THC (the chemical compound contained in marijuana that causes intoxication) to the popular Snorenz formula, not only delivers a good dose of THC, but also lubricates the throat, helping with the “dry mouth” often associated with marijuana, as well as the normal anti-snoring benefits that have made Snorenz Northstar’s biggest seller.


“We think this is a home run for Northstar. Not only are we getting a foot in the door of an emerging industry that measures in the tens of billions of dollars per year, but we are also tapping into a very specific and dedicated demographic to introduce our anti-snoring products in a way that will help grow the brand”, said Justin Sindelman, Northstar’s CEO. Sindelman went on to say, “Snorenz customers will greatly benefit from the added effects of THC. The fact that we are infusing an already popular product with the potent power of THC, and not creating just another Marijuana product, is the precise reason why this is groundbreaking. I think we are really making history, and leading the way for all supplement and food product companies that feel they have something to contribute to this explosive market.”


Shareholders can hear more about the new products and the partnership with Kush creams on Wednesday June 23rd, at 6:30 PM EST on the Pot Stock Radio. Mr. Sindelman will be interviewed along with Megan Shwartz from Kush Creams™. Both companies look forward to giving everyone a little insight on the strategy, business model and goals moving forward.


About Northstar

Northstar Global Business Services is dedicated to producing the best alternative healthcare products to the world. The company’s product line includes Snorenz®, Good Night’s Sleep®, Stem-Intense, and most recently in development is a line of medical marijuana oral sprays. Most of the company’s products use a unique or patented spray delivery system, and all have received rave consumer reviews all over the world, selling millions of units from 1996 to the present. More information can be found at www.medgeninc.com.


This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.



Leave a comment